Cite
Uterine CD56dim and CD16+ Cells in Refractory Antiphospholipid Antibody-Related Pregnancy Loss and Chromosomally Intact Abortuses: A Case-Control Study.
MLA
Gomaa, Mostafa F., et al. “Uterine CD56dim and CD16+ Cells in Refractory Antiphospholipid Antibody-Related Pregnancy Loss and Chromosomally Intact Abortuses: A Case-Control Study.” Journal of Human Reproductive Sciences, vol. 10, no. 1, Jan. 2017, pp. 18–23. EBSCOhost, https://doi.org/10.4103/jhrs.JHRS_65_16.
APA
Gomaa, M. F., Elkhouly, A. G., Farghly, M. M., Farid, L. A., & Awad, N. M. (2017). Uterine CD56dim and CD16+ Cells in Refractory Antiphospholipid Antibody-Related Pregnancy Loss and Chromosomally Intact Abortuses: A Case-Control Study. Journal of Human Reproductive Sciences, 10(1), 18–23. https://doi.org/10.4103/jhrs.JHRS_65_16
Chicago
Gomaa, Mostafa F., Abdeiiatif G. Elkhouly, Mohammad M. Farghly, Laila A. Farid, and Nahla M. Awad. 2017. “Uterine CD56dim and CD16+ Cells in Refractory Antiphospholipid Antibody-Related Pregnancy Loss and Chromosomally Intact Abortuses: A Case-Control Study.” Journal of Human Reproductive Sciences 10 (1): 18–23. doi:10.4103/jhrs.JHRS_65_16.